From Novavax’s efficacy to the elderly suffering from abuse, here are the top updates on coronavirus. Novavax’s Covid-19 vaccine showed 90% efficacy in overall clinical trials, the company said. The vaccine will be manufactured for India by the Serum Institute of India (SII). Meanwhile, a plant and root extract of velvetleaf can stop Sars-CoV-2 replication by up to 98%, as per a yet-to-be peer-reviewed study by the government’s CSIR. Also, About 73% elderly population experienced increased abuse during the second lockdown. Watch the full video for more details.

Also read – https://www.hindustantimes.com/india-news/covid-second-wave-73-elderly-suffered-from-abuse-during-lockdown-finds-study-101623678986995.html

#Covid #Novavax #Vaccine

source

By earmpy

23 thoughts on “Covid update: ‘Delta plus’ variant; plant extract & virus; Novavax shows 90% efficacy”
  1. Covid is getting updates faster than Android and IOS. Vaccine manufacturers and pharma industries ready to roll out new patch updates which obviously fails.We are fu***d totally

  2. now what is the government waiting for to find out the dangerous effects of the mutant delta plus? India was able to detect a new mutant strain in the begining of the year early jan 2021 yet they the indian scientists and so called experts couldnt trace the adversities of the entity and the aftermath havoc. They will keep numb because no one however much he or she claims to be knowledgable by earning phd or md degree fails in front of the Nature.

  3. lastly ayurveda and siddha leaf extracts wins covid battle
    i think they copied from andra pradesh miracle leaf medicine
    thank you ayush ministry

  4. Amazing how the India variant appeared just as the Sino-India conflict started…just a coincidence, I’m sure…

  5. Eagerly waiting for the next variant…which is yet to be developed 😁😂😂Indian variant …Chinese variant…Brazilian variety omg…what nxt…Variant to combat stupidity

  6. Cases have reduced a lot that's good…dont know if its cuz of less testing or not,but it's a good news nonetheless

Leave a Reply

Your email address will not be published. Required fields are marked *